Campbell Raewynn G, Farquhar Douglas, Zhao Nina, Chiu Alexander G, Adappa Nithin D, Palmer James N
Department of Otolaryngology Head and Neck Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Am J Rhinol Allergy. 2016 Jul;30(4):294-300. doi: 10.2500/ajra.2016.30.4319.
Endoscopic endonasal repair of cerebrospinal fluid (CSF) rhinorrhea secondary to idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri or benign intracranial hypertension, has varying success rates, from 25-87%, with minimal morbidity. However, often these series have a relatively short-term follow-up. Given the pathophysiology of IIH, long-term follow-up is necessary to identify true CSF leak recurrence rates. Our investigation aimed to evaluate long-term outcomes in endoscopically repaired CSF leaks.
A retrospective chart review of all the patients with CSF rhinorrhea due to IIH who met inclusion criteria between 1996 and 2009. Outcome measures included the following: demographics, intracranial pressure, location of skull base defect, presence of encephalocele and/or meningoencephalocele, surgical repair technique, treatment with acetazolamide, whether a ventriculoperitoneal shunt was inserted, location of recurrence, history of meningitis or previous sinus surgery, and duration of follow-up.
Thirty-two patients with a total of 44 skull base defects were reviewed over a mean follow-up of 10.2 years. The mean body mass index and intracranial pressure were 36.8 kg/m(2) and 27.7 cm H2O, respectively. Seven patients (18%) required revision surgery at the same site or a distant site. We found no statistical significance that identified the recurrence risk in the outcome measurements most likely due to our small failure rate. However, early recurrences were noted to recur at the same repair site, whereas late recurrences were noted to recur at a distant site along the skull base.
IIH is an increasingly recognized entity treated by otorhinolaryngologists. We present the first long-term IIH CSF leak repair series. Long-term follow-up is necessary because delayed CSF leaks occur in this population.
内镜下经鼻修复特发性颅内高压(IIH)继发的脑脊液(CSF)鼻漏,也称为假性脑瘤或良性颅内高压,成功率各不相同,为25% - 87%,且发病率极低。然而,这些系列研究通常随访时间较短。鉴于IIH的病理生理学特点,需要长期随访以确定真正的脑脊液漏复发率。我们的研究旨在评估内镜修复脑脊液漏的长期疗效。
对1996年至2009年间符合纳入标准的所有因IIH导致脑脊液鼻漏的患者进行回顾性病历审查。结局指标包括以下内容:人口统计学数据、颅内压、颅底缺损位置、脑膨出和/或脑膜脑膨出的存在情况、手术修复技术、乙酰唑胺治疗情况、是否插入脑室腹腔分流管、复发位置、脑膜炎病史或既往鼻窦手术史以及随访时间。
共对32例患者的44处颅底缺损进行了回顾,平均随访时间为10.2年。平均体重指数和颅内压分别为36.8kg/m²和27.7cmH₂O。7例患者(18%)需要在同一部位或远处部位进行翻修手术。我们发现,由于失败率较低,在结局测量中未发现确定复发风险的统计学意义。然而,早期复发多在同一修复部位,而晚期复发多在颅底远处部位。
IIH是耳鼻喉科医生越来越认识到的一种疾病。我们展示了首个长期IIH脑脊液漏修复系列研究。由于该人群会发生延迟性脑脊液漏,因此需要长期随访。